Results 161 to 170 of about 7,268 (227)

Fundamentals and emerging frontiers in p53-targeted drug development. [PDF]

Biochem Biophys Rep
Long HD, Zhang N, Wang WE, Ma YS, Liu FX, Chen ZY, Lu CN, Wang XF, Han N, Cai YF, Yang C, Tang XM, Yu H, Jiang H, Fu D, Chu KJ, Wu WG.   +16 more
europepmc   +1 more source

p53TAD accesses a second pocket in MDM2 and MDMX for tighter binding

Biophysical Journal
Guy W. Dayhoff, Pirada S. Higbee, Asokan Anbanadam, Sameer Varma, G. Daughdrill   +4 more
semanticscholar   +1 more source

MDM4 at the Crossroads: Beyond p53 and MDM2. [PDF]

Cancers (Basel)
Thapa D, St John A, Parrales A, Ranjan A, Iwakuma T.   +4 more
europepmc   +1 more source

The <i>p53</i> mRNA exhibits riboswitch-like features under DNA damage conditions. [PDF]

iScience
Chen S, Wang L, Malbert-Colas L, Karakostis K, Olivares-Illana V, Vadivel Gnanasundram S, Fahraeus R.   +6 more
europepmc   +1 more source

Targeting Mouse Double Minute 2 Homolog (MDM2) Oncogene in Breast Adenocarcinoma. [PDF]

Maedica (Bucur)
Niotis A, Mastronikoli S, Spyropoulou D, Adamopoulou M, Fotiades P, Vylliotis A, Tsantoulas A, Tsiambas E.   +7 more
europepmc   +1 more source

Pathways to precision medicine in cervical cancer: a comprehensive review of small molecule inhibitors, biomarkers and computational approaches. [PDF]

3 Biotech
Purohit N, Mishra Y, Hazarika P, Gopalakrishnan AV, Murali R.   +4 more
europepmc   +1 more source

Post-translational modifications in retinoblastoma: mechanisms, immune regulation, and therapeutic opportunities. [PDF]

Front Immunol
Xu L, Wang B, Li W, Luo X, Wang L, Zheng Y.   +5 more
europepmc   +1 more source

Patients with AML with WT TP53 but defective TP53-mediated apoptosis have a dismal survival. [PDF]

JCI Insight
Dubois J, Palmer A, King D, Rizk M, Bedi K, Shedden KA, Malek SN.   +6 more
europepmc   +1 more source

DNA Damage and Repair in Ovarian Cancer: Focus on MicroRNAs. [PDF]

Cancers (Basel)
Arczewska KD, Piekiełko-Witkowska A.
europepmc   +1 more source

Polyethylene glycol incorporation to reduce the cytotoxicity associated with cationic cell-penetrating-peptide conjugation. [PDF]

RSC Med Chem
Umezawa N, Arakawa K, Kato M, Hisamatsu Y, Yagi H, Miyajima C, Inoue Y.   +6 more
europepmc   +1 more source